Clinical trial Recruiting at 1 site Observational Ages 30 to 90

Mapping fat-cell sizes around the coronary arteries to trace inflammation

Official title: Direct Measurement of Pericoronary Adipocyte Size Gradient as a Parameter of Immunometabolic Changes of Perivascular Adipose Tissue

Run by Institute for Clinical and Experimental Medicine · NCT07360925 · Data updated 2026-11-12

This project will test whether differences in fat-cell size next to the coronary arteries can show how inflammation spreads in people having a heart transplant for advanced heart failure.

Quick facts

Study typeObservational
Ages30 Years to 90 Years
SexAll
Enrollment60 (estimated)
SponsorInstitute for Clinical and Experimental Medicine
Government
Locations1 site (Prague)
StatusRecruiting
StartedJune 1, 2023
Main results expectedJuly 1, 2028
Study endsJuly 1, 2029
Registry record updatedJanuary 22, 2026
Trial IDNCT07360925 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 30–90 with a diagnosis of dilated or ischemic cardiomyopathy who are undergoing heart transplantation at IKEM and can give informed consent.

Probably not a fit

Patients with combined dilated and ischemic cardiomyopathy, arrhythmogenic cardiomyopathy, congenital heart defects, those not undergoing transplantation at IKEM, or those unable to consent are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will collect explanted hearts during heart transplantation at IKEM from patients with ischemic or dilated cardiomyopathy. Pericoronary adipose tissue samples close to and farther from the arterial lumen will be analyzed for adipocyte size, immunometabolic markers, and macrophage changes to create spatial gradients. Clinical data including age, BMI, comorbidities, medications and prior LVAD use will be recorded to relate tissue findings to patient context and altered coronary flow. Results will compare patients with advanced atherosclerosis to those with less atherosclerotic disease to determine patterns of local inflammation propagation.

Why it matters

Potential benefit: If successful, this could reveal how local fat inflammation contributes to coronary artery disease and point to new targets for prevention or treatment.

How similar studies have gone: Previous research has linked pericoronary adipose inflammation to coronary disease, but direct mapping of adipocyte-size gradients in explanted human hearts is a relatively novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 30-90 years
* Diagnosis of dilatational or ischemic cardiomyopathy
* Patients undergoing heart transplantation in IKEM

Exclusion Criteria:

* Known combined diagnosis of dilatational and ischemic cardiomyopathy
* Arrhythmogenic cardiomyopathy
* Congenital heart defects
* Non-eligibility due to the absence of informed consent

Where it's running

  • Centre of Experimental Medicine, Institute for Clinical and Experimental Medicine,
    Prague, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.